These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35887521)

  • 1. Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States.
    Schroll MM; Agarwal A; Foroughi O; Kong E; Perez O; Pritchard D; Breur T; Garner Amanti K; Gustavsen G
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholders' expectations of precision medicine: A qualitative study to identify areas of (mis)alignment.
    Knott T; Creeden J; Horbach B; Rauch-Zumbrägel M; Vat L; Harnik H; Maravic Z
    Health Sci Rep; 2023 Aug; 6(8):e1428. PubMed ID: 37599652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMCP Partnership Forum: Managing Care in the Wave of Precision Medicine.
    J Manag Care Spec Pharm; 2018 Jul; 24(7):583-588. PubMed ID: 29952713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across Stakeholders.
    Schroll MM; Quinn E; Pritchard D; Chang A; Garner Amanti K; Perez O; Agarwal A; Gustavsen G
    J Pers Med; 2024 Jun; 14(6):. PubMed ID: 38929814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roadmap toward Personalized Medicine: Challenges and Opportunities.
    Cinti C; Trivella MG; Joulie M; Ayoub H; Frenzel M;
    J Pers Med; 2024 May; 14(6):. PubMed ID: 38929767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action.
    Baird AM; Westphalen CB; Blum S; Nafria B; Knott T; Sargeant I; Harnik H; Brooke N; Wicki N; Wong-Rieger D
    Health Sci Rep; 2023 Jun; 6(6):e1349. PubMed ID: 37359405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Assessment of the Knowledge and Perceptions of Precision Medicine (PM) in the Rwandan Healthcare Setting.
    Musanabaganwa C; Ruton H; Ruhangaza D; Nsabimana N; Kayitare E; Muvunyi TZ; Semakula M; Ntirenganya F; Musoni E; Ndoli J; Hategekimana E; Nassir A; Makokha F; Uwimana A; Gasana J; Munezero PC; Uwinkindi F; Muvunyi CM; Nyirazinyoye L; Mazarati JB; Mutesa L
    J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to g
    Foroughi O; Madraswala S; Hayes J; Glover K; Lee L; Chaki M; Redpath S; Yu AW; Chiu D; Amanti KG; Gustavsen G
    J Pers Med; 2023 Aug; 13(8):. PubMed ID: 37623478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Framework for Measuring Personalized Medicine Integration into US Healthcare Delivery Organizations.
    Agarwal A; Pritchard D; Gullett L; Amanti KG; Gustavsen G
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.
    Garrison LP; Carlson JJ; Bajaj PS; Towse A; Neumann PJ; Sullivan SD; Westrich K; Dubois RW
    Am J Manag Care; 2015 Sep; 21(9):632-40. PubMed ID: 26618366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to dissemination and adoption of precision medicine among Hispanics/Latinos.
    Canedo JR; Wilkins CH; Senft N; Romero A; Bonnet K; Schlundt D
    BMC Public Health; 2020 May; 20(1):603. PubMed ID: 32357943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosimilar Perceptions Among Healthcare Professionals and Commercial Medical Benefit Policy Analysis in the United States.
    Herndon K; Braithwaite J; Berry B; Bourget K
    BioDrugs; 2021 Jan; 35(1):103-112. PubMed ID: 33400238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges.
    Knowles L; Luth W; Bubela T
    J Law Biosci; 2017 Dec; 4(3):453-506. PubMed ID: 29868182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision reimbursement for precision medicine: the need for patient-level decisions between payers, providers and pharmaceutical companies.
    Budhdeo S; Ruhl M; Agapow PM; Sharma N; Moss P
    Future Healthc J; 2021 Nov; 8(3):e695-e698. PubMed ID: 34888469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and Awareness Toward Pharmacogenomics and Personalized Medicine Adoption Among Health Sciences Trainees: Experience from Greece and Lessons for Europe.
    Siamoglou S; Koromina M; Politopoulou K; Samiou CG; Papadopoulou G; Balasopoulou A; Kanavos A; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Mar; 25(3):190-199. PubMed ID: 33646050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the Awareness of Adoption as a Family-Building Option Among Oncofertility Stakeholders in Japan.
    Shiraishi E; Sugimoto K; Shapiro JS; Ito Y; Kamoshita K; Kusuhara A; Haino T; Koizumi T; Okamoto A; Suzuki N
    JCO Glob Oncol; 2020; 6():. PubMed ID: 32259157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.